AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metwyn G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Garwyn Remedies

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metwyn G 1mg/500mg Tablet SR

Glucowin SR tablets (1mg/500mg) are classified as antidiabetic medications, combining two active agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Glucowin SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, tremors—and implement appropriate countermeasures. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to track blood cell counts and liver function.

Uses of Metwyn G 1mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Metwyn G 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metwyn G 1mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Metwyn G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metwyn G 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Metwyn G 1mg/500mg Sustained-Release tablet with a meal.

How Metwyn G 1mg/500mg Tablet SR works:

Metformin and Glimepiride, combined as Metwyn G 1mg/500mg SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through three mechanisms: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metwyn G 1mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Metwyn G 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metwyn G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metwyn G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metwyn G 1mg/500mg SR tablet use. Physician consultation is necessary. Kidney function should be regularly monitored during treatment with this medication.

LiverLiverCAUTION

Individuals with liver impairment should use Metwyn G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, Metwyn G 1mg/500mg SR tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metwyn G 1mg/500mg Tablet SR :

Should you forget a Metwyn G 1mg/500mg SR tablet, administer it immediately if feasible. Otherwise, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.

Facts to Know About Metwyn G 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metwyn G 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metwyn G 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metwyn G 1mg/500mg Tablet SR and seek immediate medical attention.
Metwyn G 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metwyn G 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Metwyn G 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Metwyn G 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metwyn G 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Metwyn G 1mg/500mg Tablet...
43
MRP 50
14% off